Neuroscience
The Neuroscience Clinical Trials Team conducts clinical trials for patients with dementia, epilepsy, migraine and headache disorders, stroke, movement disorders and other neurological conditions.
CB03: add-on therapy for focal epilepsy
Trial status:
Recruiting
Contact:
Delphine Lévy-Bencheton
A disease modification drug for Temporal Lobe Epilepsy
A disease modification drug for Temporal Lobe Epilepsy
Trial status:
Recruiting
Contact:
Delphine Lévy-Bencheton
X-ACKT: Clinical trial of a new drug for generalised epilepsy
This study is trialing a novel anti-epileptic medication called XEN1101 in patients who suffer from primary generalized tonic-clonic seizures and have not achieved satisfactory seizure control using standard therapies.
Trial status:
Recruiting
Contact:
Delphine Lévy-Bencheton
X-TOLE2: Clinical trial of a new drug for focal epilepsy
This study is trialing a novel anti-epileptic medication called XEN1101 in focal epilepsy patients who have not achieved satisfactory seizure control on at least two anti-epileptic medications.
Trial status:
Recruiting
Contact:
Delphine Lévy-Bencheton